Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on February 11, 2009
J Am Soc Nephrol 20: 495-505, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008010009

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
ASN.2008010009v1
20/3/495    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okamura, D. M.
Right arrow Articles by Eddy, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okamura, D. M.
Right arrow Articles by Eddy, A. A.

BASIC RESEARCH

CD36 Regulates Oxidative Stress and Inflammation in Hypercholesterolemic CKD

Daryl M. Okamura*, Subramaniam Pennathur{dagger}, Katie Pasichnyk*, Jesús M. López-Guisa*, Sarah Collins*, Maria Febbraio{ddagger}, Jay Heinecke§ and Allison A. Eddy*

* Department of Pediatrics, Seattle Children's Research Institute, and § Department of Endocrinology and Metabolism, University of Washington, Seattle, Washington; {dagger} Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; and {ddagger} Department of Cell Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio

Correspondence: Dr. Daryl M. Okamura, Seattle Children's Research Institute, Division of Nephrology, 4800 Sand Point Way NE, A7931, Seattle, WA 98105. Phone: 206-987-2524; Fax: 206-987-2636; E-mail: daryl.okamura{at}seattlechildrens.org

Received for publication January 4, 2008. Accepted for publication October 15, 2008.

Scavenger receptors play a central role in atherosclerosis by processing oxidized lipoproteins and mediating their cellular effects. Recent studies suggested that the atherogenic state correlates with progression of chronic kidney disease (CKD); therefore, scavenger receptors are candidate mediators of renal fibrogenesis. Here, we investigated the role of CD36, a class B scavenger receptor, in a hypercholesterolemic model of CKD. We placed CD36-deficient mice and wild-type male mice on a high-fat Western diet for 7 to 8 wk and then performed either sham or unilateral ureteral obstruction surgery. CD36-deficient mice developed significantly less fibrosis compared with wild-type mice at days 3, 7, and 14 after obstruction. Compared with wild-type mice, CD36-deficient mice had significantly more interstitial macrophages at 7 d but not at 14 d. CD36-deficient mice exhibited reduced levels of activated NF-{kappa}B and oxidative stress (assessed by measuring fatty acid–derived hydroxyoctadecadienoic acid and protein carbonyl content) and decreased accumulation of interstitial myofibroblasts compared with wild-type mice. These data suggest that CD36 is a key modulator of proinflammatory and oxidative pathways that promote fibrogenesis in CKD.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. L. Lin, A. P. Castano, B. T. Nowlin, M. L. Lupher Jr., and J. S. Duffield
Bone Marrow Ly6Chigh Monocytes Are Selectively Recruited to Injured Kidney and Differentiate into Functionally Distinct Populations
J. Immunol., November 15, 2009; 183(10): 6733 - 6743.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP